These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 15670720

  • 21. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
    Christensen E, Grønn M, Hagve TA, Kase BF, Christophersen BO.
    Biochim Biophys Acta; 1989 Mar 14; 1002(1):79-83. PubMed ID: 2538146
    [Abstract] [Full Text] [Related]

  • 22. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
    Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J.
    J Biol Chem; 2013 Jun 28; 288(26):19269-79. PubMed ID: 23671276
    [Abstract] [Full Text] [Related]

  • 23. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
    Singh J, Khan M, Singh I.
    J Lipid Res; 2011 Nov 28; 52(11):2056-69. PubMed ID: 21891797
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency.
    Abe Y, Honsho M, Nakanishi H, Taguchi R, Fujiki Y.
    Biochim Biophys Acta; 2014 Apr 04; 1841(4):610-9. PubMed ID: 24418004
    [Abstract] [Full Text] [Related]

  • 26. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
    Deon M, Garcia MP, Sitta A, Barschak AG, Coelho DM, Schimit GO, Pigatto M, Jardim LB, Wajner M, Giugliani R, Vargas CR.
    Metab Brain Dis; 2008 Mar 04; 23(1):43-9. PubMed ID: 18026827
    [Abstract] [Full Text] [Related]

  • 27. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy.
    Ofman R, Dijkstra IM, van Roermund CW, Burger N, Turkenburg M, van Cruchten A, van Engen CE, Wanders RJ, Kemp S.
    EMBO Mol Med; 2010 Mar 04; 2(3):90-7. PubMed ID: 20166112
    [Abstract] [Full Text] [Related]

  • 28. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Rocchiccioli F, Cartier N, Jambaqué I, Jakobezak C, Lemaitre A, Boureau F, Wolf C.
    N Engl J Med; 1993 Sep 09; 329(11):745-52. PubMed ID: 8350883
    [Abstract] [Full Text] [Related]

  • 29. Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy.
    Sandhir R, Khan M, Chahal A, Singh I.
    J Lipid Res; 1998 Nov 09; 39(11):2161-71. PubMed ID: 9799802
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.
    Ahmed MA, Kartha RV, Brundage RC, Cloyd J, Basu C, Carlin BP, Jones RO, Moser AB, Fatemi A, Raymond GV.
    Br J Clin Pharmacol; 2016 Jun 09; 81(6):1058-66. PubMed ID: 26836218
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
    Engelen M, Schackmann MJ, Ofman R, Sanders RJ, Dijkstra IM, Houten SM, Fourcade S, Pujol A, Poll-The BT, Wanders RJ, Kemp S.
    J Inherit Metab Dis; 2012 Nov 09; 35(6):1137-45. PubMed ID: 22447153
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
    Braiterman LT, Watkins PA, Moser AB, Smith KD.
    Mol Genet Metab; 1999 Feb 09; 66(2):91-9. PubMed ID: 10068511
    [Abstract] [Full Text] [Related]

  • 40. Effects of the testosterone metabolite dihydrotestosterone and 5 alpha-androstan-3 alpha,17 beta-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts.
    Petroni A, Blasevich M, Uziel G.
    Life Sci; 2003 Aug 08; 73(12):1567-75. PubMed ID: 12865096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.